{"id":539,"date":"2025-10-15T16:00:42","date_gmt":"2025-10-15T08:00:42","guid":{"rendered":"http:\/\/www.metabiopharma.com.hk\/?p=539"},"modified":"2025-10-15T16:08:31","modified_gmt":"2025-10-15T08:08:31","slug":"meta_progress_mo_da_sheng_wu_zheng_shi_que_ren_mp-5342_wei_yan_zheng_xing_chang_bing_de_lin_chuang_k","status":"publish","type":"post","link":"http:\/\/www.metabiopharma.com.hk\/index.php\/2025\/10\/15\/meta_progress_mo_da_sheng_wu_zheng_shi_que_ren_mp-5342_wei_yan_zheng_xing_chang_bing_de_lin_chuang_k\/","title":{"rendered":"META Progress | \u9ed8\u8fbe\u751f\u7269\u6b63\u5f0f\u786e\u8ba4MP-5342\u4e3a\u708e\u75c7\u6027\u80a0\u75c5\u7684\u4e34\u5e8a\u5f00\u53d1\u5019\u9009\u5206\u5b50"},"content":{"rendered":"\n<p><strong>\u25cf\u9996\u4e2a\u6e90\u81ea\u9776\u5411\u514d\u75ab\u4ee3\u8c22\u521b\u65b0\u5e73\u53f0\u7684\u5019\u9009\u5206\u5b50\u5b8c\u6210\u4e34\u5e8a\u524d\u5f00\u53d1\uff0c\u5373\u5c06\u8fdb\u5165IND-enabling\u7814\u7a76\u9636\u6bb5<\/strong><\/p>\n\n\n\n<p><strong>\u25cf\u4e34\u5e8a\u524d\u6570\u636e\u5305\u9a8c\u8bc1\u4e86\u4e73\u9178\u8131\u6c22\u9176\u4f5c\u4e3a\u591a\u79cd\u708e\u75c7\u6027\u75be\u75c5\uff08IBD\u3001MS\u3001PBC\u7b49\uff09\u6cbb\u7597\u65b0\u9776\u70b9\u7684\u6f5c\u529b<\/strong><\/p>\n\n\n\n<p><strong>\u25cf\u57fa\u4e8e\u575a\u5b9e\u7684\u4eba\u7c7b\u8f6c\u5316\u533b\u5b66\u6570\u636e\uff0c\u9996\u9009\u9002\u5e94\u75c7\u786e\u5b9a\u4e3a\u708e\u75c7\u6027\u80a0\u75c5<\/strong><\/p>\n\n\n\n<p><strong>\u25cf\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u51c6\u5907\u5de5\u4f5c\u5df2\u542f\u52a8\uff0c\u9884\u8ba1\u4e8e2026\u5e74H2\u8fdb\u5165\u4e34\u5e8a\u9636\u6bb5<\/strong><\/p>\n\n\n\n<p>\u9ed8\u8fbe\u751f\u7269\u662f\u4e00\u5bb6\u4e13\u6ce8\u4e8e\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u53ca\u4ee3\u8c22\u75be\u75c5\u836f\u7269\u7814\u53d1\u7684\u521b\u65b0\u836f\u7269\u516c\u53f8\u3002\u516c\u53f8\u4e8e\u8fd1\u671f\u5b8c\u6210\u708e\u75c7\u6027\u80a0\u75c5\uff08IBD\uff09\u7ba1\u7ebf\u4e34\u5e8a\u5f00\u53d1\u5019\u9009\u5206\u5b50\uff08PCC\uff09\u7684\u5173\u952e\u6d4b\u8bd5\u5de5\u4f5c\uff0c\u6b63\u5f0f\u5ba3\u5e03\u786e\u8ba4MP-5342\u4f5c\u4e3a\u5176\u9996\u4e2a\u4e34\u5e8a\u5f00\u53d1\u5019\u9009\u5206\u5b50\u3002\u8be5\u5206\u5b50\u5c06\u8fdb\u5165\u6cd5\u89c4\u8981\u6c42\u7684\u4e34\u5e8a\u524d\u7814\u7a76\u9636\u6bb5\uff0c\u4ee5\u652f\u6301\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u7684\u63d0\u4ea4\u3002<\/p>\n\n\n\n<p><strong>MP-5342\u662f\u4e00\u79cd\u53e3\u670d\u3001\u9776\u5411\u4e14\u65e8\u5728\u6539\u53d8\u75be\u75c5\u8fdb\u7a0b\u7684\u6297\u708e\u7597\u6cd5\uff0c\u5177\u5907\u6210\u4e3a\u540c\u7c7b\u9996\u521b\uff08First-in-class\uff09\u7684\u6f5c\u529b\u3002<\/strong>\u5176\u9776\u5411\u4e00\u79cd\u8c03\u63a7\u7ec6\u80de\u8461\u8404\u7cd6\u4ee3\u8c22\u7684\u5173\u952e\u9176\u2014\u2014\u4e73\u9178\u8131\u6c22\u9176\uff08LDH\uff09\u3002\u901a\u8fc7\u6291\u5236LDH\uff0cMP-5342\u53ef\u8c03\u8282T\u7ec6\u80de\u548cB\u7ec6\u80de\u529f\u80fd\uff0c\u4e3a\u708e\u75c7\u6027\u75be\u75c5\u63d0\u4f9b\u5168\u65b0\u6cbb\u7597\u7b56\u7565\uff0c\u6709\u671b\u91cd\u5851\u514d\u75ab\u5e73\u8861\uff0c\u4f7f\u5f02\u5e38\u514d\u75ab\u7ec6\u80de\u529f\u80fd\u6062\u590d\u6b63\u5e38\uff0c\u4e3a\u5f53\u524d\u6cbb\u7597\u9009\u62e9\u6709\u9650\u7684\u60a3\u8005\u5e26\u6765\u6301\u4e45\u7f13\u89e3[1][2][3]\u3002<\/p>\n\n\n\n<p><strong>\u4f5c\u4e3a\u5168\u7403\u9996\u4e2a\u9ad8\u9009\u62e9\u6027\u3001\u5177\u6709\u4f18\u79c0\u4f53\u5185\u6210\u836f\u6027\u7684\u53e3\u670dLDH\u5c0f\u5206\u5b50\u6291\u5236\u5242\uff0cMP-5342\u5728\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u75c5\u4e2d\u5c55\u73b0\u51fa\u5e7f\u6cdb\u6f5c\u529b\uff0c\u5305\u62ec\u708e\u75c7\u6027\u80a0\u75c5\uff08IBD\uff09\u3001\u591a\u53d1\u6027\u786c\u5316\u75c7\uff08MS\uff09\u53ca\u539f\u53d1\u6027\u80c6\u7ba1\u708e\uff08PBC\uff09<\/strong>\u7b49\u3002\u4e73\u9178\u8131\u6c22\u9176\u5728\u81ea\u8eab\u514d\u75ab\u75c5\u708e\u75c7\u53cd\u5e94\u4e2d\u662f\u514d\u75ab\u7ec6\u80de\u80fd\u91cf\u4ee3\u8c22\u7684\u6838\u5fc3\u9176\uff0c\u56e0\u6b64\u5176\u7279\u5f02\u6027\u6291\u5236\u4e3a\u75be\u75c5\u5e72\u9884\u63d0\u4f9b\u4e86\u521b\u65b0\u9014\u5f84\u3002<\/p>\n\n\n\n<p>\u9ed8\u8fbe\u751f\u7269\u7684\u957f\u671f\u5408\u4f5c\u4f19\u4f34\u2014\u2014\u6676\u6cf0\u79d1\u6280\uff0c\u5728\u8be5\u9879\u76ee\u7684\u836f\u7269\u53d1\u73b0\u4e2d\u901a\u8fc7\u72ec\u6709\u7684FEP\u8ba1\u7b97\u548c\u81ea\u52a8\u5316\u5408\u6210\u5e73\u53f0\uff0c\u52a0\u901f\u4e86\u8be5\u9879\u76ee\u5206\u5b50\u7684\u7b5b\u9009\u8fc7\u7a0b\uff0c\u52a9\u529b\u9ed8\u8fbe\u751f\u7269\u7814\u53d1\u9879\u76ee\u9ad8\u6548\u987a\u5229\u63a8\u8fdb\u3002<\/p>\n\n\n\n<p><strong>\u9ed8\u8fbe\u751f\u7269CEO\u8bb8\u67ef\u535a\u58eb\u8868\u793a\uff1a<\/strong>\u786e\u8ba4MP-5342\u4f5c\u4e3a\u6211\u4eec\u9488\u5bf9\u708e\u75c7\u6027\u80a0\u75c5\uff08IBD\uff09\u7684\u9996\u4e2a\u4e34\u5e8a\u5f00\u53d1\u5019\u9009\u5206\u5b50\uff0c\u5bf9\u9ed8\u8fbe\u751f\u7269\u800c\u8a00\u662f\u4e00\u4e2a\u6781\u5176\u4ee4\u4eba\u5174\u594b\u7684\u8fdb\u5c55\uff0c\u4e5f\u662f\u6211\u4eec\u5411\u4e34\u5e8a\u9636\u6bb5\u516c\u53f8\u8f6c\u578b\u7684\u91cd\u8981\u91cc\u7a0b\u7891\u3002\u516c\u53f8\u7684\u79d1\u7814\u56e2\u961f\u57fa\u4e8e\u79d1\u5b66\u754c\u5bf9\u4e73\u9178\u8131\u6c22\u9176\uff08LDH\uff09\u5728\u708e\u75c7\u6027\u80a0\u75c5\u53d1\u75c5\u673a\u5236\u4e2d\u4f5c\u7528\u7684\u6df1\u5165\u7406\u89e3\uff0c\u5efa\u7acb\u4e86\u624e\u5b9e\u7684\u4e34\u5e8a\u524d\u6570\u636e\u5305\u3002\u8fd9\u4e9b\u6570\u636e\u7ed9\u4e88\u4e86\u6211\u4eec\u5c06\u8be5\u9879\u76ee\u63a8\u5411\u4e34\u5e8a\u7684\u4fe1\u5fc3\uff0c\u6211\u4eec\u671f\u5f85\u5176\u540e\u7eed\u7684\u8fdb\u5c55\u3002<\/p>\n\n\n\n<p><strong>\u9ed8\u8fbe\u751f\u7269CTO\u9c9c\u4e8e\u5b89\u4eca\u535a\u58eb\u8868\u793a\uff1a<\/strong>\u708e\u75c7\u6027\u80a0\u75c5\uff08IBD\uff09\u662f\u4e00\u79cd\u6162\u6027\u3001\u81f4\u8870\u6027\u7684\u75be\u75c5\uff0c\u60a3\u8005\u5bf9\u80fd\u591f\u6539\u53d8\u75be\u75c5\u8fdb\u7a0b\u7684\u65b0\u578b\u7597\u6cd5\u5b58\u5728\u5de8\u5927\u672a\u6ee1\u8db3\u9700\u6c42\u3002\u73b0\u6709\u6cbb\u7597\u5728\u7597\u6548\u548c\u5b89\u5168\u6027\u65b9\u9762\u4ecd\u6709\u5c40\u9650\u3002\u9ed8\u8fbe\u751f\u7269\u5728\u5176\u4e3b\u8981\u5019\u9009\u5206\u5b50MP-5342\u4e0a\u53d6\u5f97\u4e86\u91cd\u5927\u8fdb\u5c55\uff0c\u8fd9\u662f\u4e00\u79cd\u53e3\u670d\u7684\u65b0\u578b\u9776\u5411\u7597\u6cd5\uff0c\u6709\u671b\u4e3a\u60a3\u8005\u5e26\u6765\u663e\u8457\u83b7\u76ca\u3002<\/p>\n\n\n\n<p><strong>\u76ee\u524d\uff0cMP-5342\u7684\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\u7533\u8bf7\u51c6\u5907\u5de5\u4f5c\u6b63\u5728\u8fdb\u884c\u4e2d\uff0c\u9884\u8ba1\u4e34\u5e8a\u8bd5\u9a8c\u5c06\u4e8e2026\u5e74\u4e0b\u534a\u5e74\u5f00\u59cb\u3002<\/strong><\/p>\n\n\n\n<p>\u4f5c\u4e3a\u9ed8\u8fbe\u751f\u7269\u7ba1\u7ebf\u4e2d\u9996\u4e2a\u5c06\u8fdb\u5165\u4e34\u5e8a\u5f00\u53d1\u7684\u9879\u76ee\uff0cMP-5342\u4e0d\u4ec5\u5f70\u663e\u4e86\u516c\u53f8\u5728\u514d\u75ab\u4ee3\u8c22\u521b\u65b0\u9886\u57df\u7684\u7814\u53d1\u5b9e\u529b\uff0c\u4e5f\u6807\u5fd7\u7740\u6211\u4eec\u5728\u63a8\u52a8\u4ee3\u8c22\u8c03\u63a7\u7597\u6cd5\u8d70\u5411\u4e34\u5e8a\u5e94\u7528\u65b9\u9762\u8fc8\u51fa\u4e86\u5173\u952e\u4e00\u6b65\u3002<\/p>\n\n\n\n<p><strong>References<\/strong><\/p>\n\n\n\n<p>[1].Peng M, Yin N, Chhangawala S, et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354(6311):481\u2013484. DOI: 10.1126\/science.aaf6284.<\/p>\n\n\n\n<p>[2].Xu K, Yin N, Peng M, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371(6527):405\u2013410. DOI: 10.1126\/science.abb2683.<\/p>\n\n\n\n<p>[3].Xu K, Yin N, Peng M, et al. Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses. Immunity. 2021;54(5):976\u2013987. DOI: 10.1016\/j.immuni.2021.04.008.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u25cf\u9996\u4e2a\u6e90\u81ea\u9776\u5411\u514d\u75ab\u4ee3\u8c22\u521b\u65b0\u5e73\u53f0\u7684\u5019\u9009\u5206\u5b50\u5b8c\u6210\u4e34\u5e8a\u524d\u5f00\u53d1\uff0c\u5373\u5c06\u8fdb\u5165IND-enabling\u7814\u7a76\u9636\u6bb5 \u25cf\u4e34\u5e8a\u524d\u6570\u636e [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[],"_links":{"self":[{"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/posts\/539"}],"collection":[{"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/comments?post=539"}],"version-history":[{"count":4,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/posts\/539\/revisions"}],"predecessor-version":[{"id":544,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/posts\/539\/revisions\/544"}],"wp:attachment":[{"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/media?parent=539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/categories?post=539"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.metabiopharma.com.hk\/index.php\/wp-json\/wp\/v2\/tags?post=539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}